This webinar is the third of a webinar series dedicated to Angelman syndrome, a neurogenetic disorder. In this session leading experts will break down the therapeutic strategies that are being developed to treat Angelman syndrome. Our goal is to provide a clear overview of the therapeutic pillars currently being investigated — from approaches aimed at fixing the maternal gene, to unsilencing the paternal gene, to targeting downstream pathways that may improve cellular function.
Date: 25 November, 5 PM (CET)
HERE to register and to see the full program